Founded in 2006, Ocular Therapeutix, Inc. is a privately held company focused on the development and commercialization of ophthalmic therapeutic products using its proprietary polyethylene glycol (PEG) hydrogel technology to address unmet or underserved needs in ophthalmology and ophthalmic surgery. The company’s first product, ReSure® Adherent Ocular Bandage, is a synthetic ocular bandage designed and indicated for use in cataract and intraocular lens placement surgeries to reduce pain and discomfort in the days following surgery. The ReSure Adherent Ocular Bandage is CE Mark approved and commercially available in select European markets only.
Ocular Therapeutix is also developing sustained drug delivery vehicles for the therapy and treatment of ocular diseases. The company’s drug delivery technology is compatible with a wide range of ophthalmic medications, including those for glaucoma, dry eye, conjunctivitis, and allergies.